Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Acute myeloid leukemia
| Copanlisib | 121 1件: 121 💬1. Acute myeloid leukemia
|
||||||||||||||
| 2 | AGE-RAGE signaling pathway in diabetic complications 💬 28 genes, 55 drugs (DrugBank) and 96 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬AGE-RAGE signaling pathway in diabetic complications
| Copanlisib | 121 1件: 121 💬2. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||
| 3 | Aldosterone-regulated sodium reabsorption 💬 13 genes, 17 drugs (DrugBank) and 30 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Aldosterone-regulated sodium reabsorption
| Copanlisib | 121 1件: 121 💬3. Aldosterone-regulated sodium reabsorption
|
||||||||||||||
| 4 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Alzheimer disease
| Copanlisib | 121 1件: 121 💬4. Alzheimer disease
|
||||||||||||||
| 5 | Amoebiasis 💬 20 genes, 32 drugs (DrugBank) and 71 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Amoebiasis
| Copanlisib | 121 1件: 121 💬5. Amoebiasis
|
||||||||||||||
| 6 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬AMPK signaling pathway
| Copanlisib | 121 1件: 121 💬6. AMPK signaling pathway
|
||||||||||||||
| 7 | Apoptosis 💬 17 genes, 31 drugs (DrugBank) and 64 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Apoptosis
| Copanlisib | 121 1件: 121 💬7. Apoptosis
|
||||||||||||||
| 8 | Autophagy - animal 💬 14 genes, 20 drugs (DrugBank) and 67 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Autophagy - animal
| Copanlisib | 121 1件: 121 💬8. Autophagy - animal
|
||||||||||||||
| 9 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Axon guidance
| Copanlisib | 121 1件: 121 💬9. Axon guidance
|
||||||||||||||
| 10 | B cell receptor signaling pathway 💬 19 genes, 39 drugs (DrugBank) and 68 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬B cell receptor signaling pathway
| Copanlisib | 121 1件: 121 💬10. B cell receptor signaling pathway
|
||||||||||||||
| 11 | Bacterial invasion of epithelial cells 💬 7 genes, 10 drugs (DrugBank) and 19 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Bacterial invasion of epithelial cells
| Copanlisib | 121 1件: 121 💬11. Bacterial invasion of epithelial cells
|
||||||||||||||
| 12 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Breast cancer
| Copanlisib | 121 1件: 121 💬12. Breast cancer
|
||||||||||||||
| 13 | C-type lectin receptor signaling pathway 💬 27 genes, 66 drugs (DrugBank) and 102 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬C-type lectin receptor signaling pathway
| Copanlisib | 121 1件: 121 💬13. C-type lectin receptor signaling pathway
|
||||||||||||||
| 14 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬cAMP signaling pathway
| Copanlisib | 121 1件: 121 💬14. cAMP signaling pathway
|
||||||||||||||
| 15 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Carbohydrate digestion and absorption
| Copanlisib | 121 1件: 121 💬15. Carbohydrate digestion and absorption
|
||||||||||||||
| 16 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Cellular senescence
| Copanlisib | 121 1件: 121 💬16. Cellular senescence
|
||||||||||||||
| 17 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Central carbon metabolism in cancer
| Copanlisib | 121 1件: 121 💬17. Central carbon metabolism in cancer
|
||||||||||||||
| 18 | Chagas disease 💬 31 genes, 56 drugs (DrugBank) and 87 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chagas disease
| Copanlisib | 121 1件: 121 💬18. Chagas disease
|
||||||||||||||
| 19 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemical carcinogenesis - reactive oxygen species
| Copanlisib | 121 1件: 121 💬19. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||
| 20 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemical carcinogenesis - receptor activation
| Copanlisib | 121 1件: 121 💬20. Chemical carcinogenesis - receptor activation
|
||||||||||||||
| 21 | Chemokine signaling pathway 💬 23 genes, 38 drugs (DrugBank) and 64 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chemokine signaling pathway
| Copanlisib | 121 1件: 121 💬21. Chemokine signaling pathway
|
||||||||||||||
| 22 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Choline metabolism in cancer
| Copanlisib | 121 1件: 121 💬22. Choline metabolism in cancer
|
||||||||||||||
| 23 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Cholinergic synapse
| Copanlisib | 121 1件: 121 💬23. Cholinergic synapse
|
||||||||||||||
| 24 | Chronic myeloid leukemia 💬 17 genes, 23 drugs (DrugBank) and 36 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Chronic myeloid leukemia
| Copanlisib | 121 1件: 121 💬24. Chronic myeloid leukemia
|
||||||||||||||
| 25 | Colorectal cancer 💬 14 genes, 26 drugs (DrugBank) and 59 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Colorectal cancer
| Copanlisib | 121 1件: 121 💬25. Colorectal cancer
|
||||||||||||||
| 26 | Coronavirus disease - COVID-19 💬 54 genes, 108 drugs (DrugBank) and 105 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Coronavirus disease - COVID-19
| Copanlisib | 121 1件: 121 💬26. Coronavirus disease - COVID-19
|
||||||||||||||
| 27 | Diabetic cardiomyopathy 💬 28 genes, 48 drugs (DrugBank) and 79 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Diabetic cardiomyopathy
| Copanlisib | 121 1件: 121 💬27. Diabetic cardiomyopathy
|
||||||||||||||
| 28 | Endometrial cancer 💬 10 genes, 20 drugs (DrugBank) and 28 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Endometrial cancer
| Copanlisib | 121 1件: 121 💬28. Endometrial cancer
|
||||||||||||||
| 29 | Epstein-Barr virus infection 💬 67 genes, 90 drugs (DrugBank) and 82 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Epstein-Barr virus infection
| Copanlisib | 121 1件: 121 💬29. Epstein-Barr virus infection
|
||||||||||||||
| 30 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬ErbB signaling pathway
| Copanlisib | 121 1件: 121 💬30. ErbB signaling pathway
|
||||||||||||||
| 31 | Estrogen signaling pathway 💬 21 genes, 81 drugs (DrugBank) and 73 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Estrogen signaling pathway
| Copanlisib | 121 1件: 121 💬31. Estrogen signaling pathway
|
||||||||||||||
| 32 | Fc epsilon RI signaling pathway 💬 19 genes, 50 drugs (DrugBank) and 68 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fc epsilon RI signaling pathway
| Copanlisib | 121 1件: 121 💬32. Fc epsilon RI signaling pathway
|
||||||||||||||
| 33 | Fc gamma R-mediated phagocytosis 💬 9 genes, 14 drugs (DrugBank) and 20 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fc gamma R-mediated phagocytosis
| Copanlisib | 121 1件: 121 💬33. Fc gamma R-mediated phagocytosis
|
||||||||||||||
| 34 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Fluid shear stress and atherosclerosis
| Copanlisib | 121 1件: 121 💬34. Fluid shear stress and atherosclerosis
|
||||||||||||||
| 35 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Focal adhesion
| Copanlisib | 121 1件: 121 💬35. Focal adhesion
|
||||||||||||||
| 36 | FoxO signaling pathway 💬 25 genes, 43 drugs (DrugBank) and 60 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬FoxO signaling pathway
| Copanlisib | 121 1件: 121 💬36. FoxO signaling pathway
|
||||||||||||||
| 37 | Gastric cancer 💬 22 genes, 40 drugs (DrugBank) and 66 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Gastric cancer
| Copanlisib | 121 1件: 121 💬37. Gastric cancer
|
||||||||||||||
| 38 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Glioma
| Copanlisib | 121 1件: 121 💬38. Glioma
|
||||||||||||||
| 39 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬GnRH secretion
| Copanlisib | 121 1件: 121 💬39. GnRH secretion
|
||||||||||||||
| 40 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Growth hormone synthesis, secretion and action
| Copanlisib | 121 1件: 121 💬40. Growth hormone synthesis, secretion and action
|
||||||||||||||
| 41 | Hepatitis B 💬 43 genes, 65 drugs (DrugBank) and 87 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatitis B
| Copanlisib | 121 1件: 121 💬41. Hepatitis B
|
||||||||||||||
| 42 | Hepatitis C 💬 36 genes, 70 drugs (DrugBank) and 87 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatitis C
| Copanlisib | 121 1件: 121 💬42. Hepatitis C
|
||||||||||||||
| 43 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hepatocellular carcinoma
| Copanlisib | 121 1件: 121 💬43. Hepatocellular carcinoma
|
||||||||||||||
| 44 | Herpes simplex virus 1 infection 💬 70 genes, 80 drugs (DrugBank) and 107 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Herpes simplex virus 1 infection
| Copanlisib | 121 1件: 121 💬44. Herpes simplex virus 1 infection
|
||||||||||||||
| 45 | HIF-1 signaling pathway 💬 26 genes, 56 drugs (DrugBank) and 87 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬HIF-1 signaling pathway
| Copanlisib | 121 1件: 121 💬45. HIF-1 signaling pathway
|
||||||||||||||
| 46 | Hormone signaling 💬 66 genes, 211 drugs (DrugBank) and 153 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Hormone signaling
| Copanlisib | 121 1件: 121 💬46. Hormone signaling
|
||||||||||||||
| 47 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human cytomegalovirus infection
| Copanlisib | 121 1件: 121 💬47. Human cytomegalovirus infection
|
||||||||||||||
| 48 | Human immunodeficiency virus 1 infection 💬 50 genes, 57 drugs (DrugBank) and 95 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human immunodeficiency virus 1 infection
| Copanlisib | 121 1件: 121 💬48. Human immunodeficiency virus 1 infection
|
||||||||||||||
| 49 | Human papillomavirus infection 💬 51 genes, 106 drugs (DrugBank) and 115 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human papillomavirus infection
| Copanlisib | 121 1件: 121 💬49. Human papillomavirus infection
|
||||||||||||||
| 50 | Human T-cell leukemia virus 1 infection 💬 59 genes, 74 drugs (DrugBank) and 96 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Human T-cell leukemia virus 1 infection
| Copanlisib | 121 1件: 121 💬50. Human T-cell leukemia virus 1 infection
|
||||||||||||||
| 51 | Inflammatory mediator regulation of TRP channels 💬 25 genes, 53 drugs (DrugBank) and 65 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Inflammatory mediator regulation of TRP channels
| Copanlisib | 121 1件: 121 💬51. Inflammatory mediator regulation of TRP channels
|
||||||||||||||
| 52 | Influenza A 💬 65 genes, 78 drugs (DrugBank) and 98 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Influenza A
| Copanlisib | 121 1件: 121 💬52. Influenza A
|
||||||||||||||
| 53 | Inositol phosphate metabolism 💬 4 genes, 5 drugs (DrugBank) and 10 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Inositol phosphate metabolism
| Copanlisib | 121 1件: 121 💬53. Inositol phosphate metabolism
|
||||||||||||||
| 54 | Insulin resistance 💬 19 genes, 38 drugs (DrugBank) and 100 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Insulin resistance
| Copanlisib | 121 1件: 121 💬54. Insulin resistance
|
||||||||||||||
| 55 | Insulin signaling pathway 💬 12 genes, 28 drugs (DrugBank) and 71 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Insulin signaling pathway
| Copanlisib | 121 1件: 121 💬55. Insulin signaling pathway
|
||||||||||||||
| 56 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬JAK-STAT signaling pathway
| Copanlisib | 121 1件: 121 💬56. JAK-STAT signaling pathway
|
||||||||||||||
| 57 | Kaposi sarcoma-associated herpesvirus infection 💬 60 genes, 94 drugs (DrugBank) and 118 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Kaposi sarcoma-associated herpesvirus infection
| Copanlisib | 121 1件: 121 💬57. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||
| 58 | Leukocyte transendothelial migration 💬 18 genes, 23 drugs (DrugBank) and 44 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Leukocyte transendothelial migration
| Copanlisib | 121 1件: 121 💬58. Leukocyte transendothelial migration
|
||||||||||||||
| 59 | Lipid and atherosclerosis 💬 51 genes, 71 drugs (DrugBank) and 103 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Lipid and atherosclerosis
| Copanlisib | 121 1件: 121 💬59. Lipid and atherosclerosis
|
||||||||||||||
| 60 | Longevity regulating pathway 💬 11 genes, 22 drugs (DrugBank) and 71 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Longevity regulating pathway
| Copanlisib | 121 1件: 121 💬60. Longevity regulating pathway
|
||||||||||||||
| 61 | Longevity regulating pathway - multiple species 💬 11 genes, 18 drugs (DrugBank) and 66 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Longevity regulating pathway - multiple species
| Copanlisib | 121 1件: 121 💬61. Longevity regulating pathway - multiple species
|
||||||||||||||
| 62 | Measles 💬 42 genes, 63 drugs (DrugBank) and 68 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Measles
| Copanlisib | 121 1件: 121 💬62. Measles
|
||||||||||||||
| 63 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Melanoma
| Copanlisib | 121 1件: 121 💬63. Melanoma
|
||||||||||||||
| 64 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬MicroRNAs in cancer
| Copanlisib | 121 1件: 121 💬64. MicroRNAs in cancer
|
||||||||||||||
| 65 | mTOR signaling pathway 💬 14 genes, 33 drugs (DrugBank) and 95 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬mTOR signaling pathway
| Copanlisib | 121 1件: 121 💬65. mTOR signaling pathway
|
||||||||||||||
| 66 | Natural killer cell mediated cytotoxicity 💬 44 genes, 50 drugs (DrugBank) and 86 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Natural killer cell mediated cytotoxicity
| Copanlisib | 121 1件: 121 💬66. Natural killer cell mediated cytotoxicity
|
||||||||||||||
| 67 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 2件: SLC6A2, SLC6A4 💬
|
Desipramine hydrochloride Desipramine hydrochloride 💬Neuroactive ligand signaling
| Desipramine | 121 1件: 121 💬67. Neuroactive ligand signaling
|
||||||||||||||
| 68 | Neuroactive ligand signaling 💬 92 genes, 239 drugs (DrugBank) and 117 diseases |
SLC6A2 2件: SLC6A2, SLC6A4 💬
|
Desipramine Desipramine 💬Neuroactive ligand signaling
| Desipramine | 121 1件: 121 💬67. Neuroactive ligand signaling
|
||||||||||||||
| 69 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 37 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Neurotrophin signaling pathway
| Copanlisib | 121 1件: 121 💬69. Neurotrophin signaling pathway
|
||||||||||||||
| 70 | Neutrophil extracellular trap formation 💬 36 genes, 46 drugs (DrugBank) and 77 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Neutrophil extracellular trap formation
| Copanlisib | 121 1件: 121 💬70. Neutrophil extracellular trap formation
|
||||||||||||||
| 71 | Non-alcoholic fatty liver disease 💬 23 genes, 52 drugs (DrugBank) and 95 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Non-alcoholic fatty liver disease
| Copanlisib | 121 1件: 121 💬71. Non-alcoholic fatty liver disease
|
||||||||||||||
| 72 | Non-small cell lung cancer 💬 21 genes, 40 drugs (DrugBank) and 58 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Non-small cell lung cancer
| Copanlisib | 121 1件: 121 💬72. Non-small cell lung cancer
|
||||||||||||||
| 73 | Osteoclast differentiation 💬 38 genes, 86 drugs (DrugBank) and 102 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Osteoclast differentiation
| Copanlisib | 121 1件: 121 💬73. Osteoclast differentiation
|
||||||||||||||
| 74 | Pancreatic cancer 💬 19 genes, 40 drugs (DrugBank) and 84 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Pancreatic cancer
| Copanlisib | 121 1件: 121 💬74. Pancreatic cancer
|
||||||||||||||
| 75 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Pathways in cancer
| Copanlisib | 121 1件: 121 💬75. Pathways in cancer
|
||||||||||||||
| 76 | PD-L1 expression and PD-1 checkpoint pathway in cancer 💬 35 genes, 66 drugs (DrugBank) and 100 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬PD-L1 expression and PD-1 checkpoint pathway in cancer
| Copanlisib | 121 1件: 121 💬76. PD-L1 expression and PD-1 checkpoint pathway in cancer
|
||||||||||||||
| 77 | Phosphatidylinositol signaling system 💬 5 genes, 6 drugs (DrugBank) and 11 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Phosphatidylinositol signaling system
| Copanlisib | 121 1件: 121 💬77. Phosphatidylinositol signaling system
|
||||||||||||||
| 78 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Phospholipase D signaling pathway
| Copanlisib | 121 1件: 121 💬78. Phospholipase D signaling pathway
|
||||||||||||||
| 79 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬PI3K-Akt signaling pathway
| Copanlisib | 121 1件: 121 💬79. PI3K-Akt signaling pathway
|
||||||||||||||
| 80 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Platelet activation
| Copanlisib | 121 1件: 121 💬80. Platelet activation
|
||||||||||||||
| 81 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prion disease
| Copanlisib | 121 1件: 121 💬81. Prion disease
|
||||||||||||||
| 82 | Progesterone-mediated oocyte maturation 💬 14 genes, 38 drugs (DrugBank) and 46 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Progesterone-mediated oocyte maturation
| Copanlisib | 121 1件: 121 💬82. Progesterone-mediated oocyte maturation
|
||||||||||||||
| 83 | Prolactin signaling pathway 💬 19 genes, 43 drugs (DrugBank) and 70 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prolactin signaling pathway
| Copanlisib | 121 1件: 121 💬83. Prolactin signaling pathway
|
||||||||||||||
| 84 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Prostate cancer
| Copanlisib | 121 1件: 121 💬84. Prostate cancer
|
||||||||||||||
| 85 | Proteoglycans in cancer 💬 33 genes, 73 drugs (DrugBank) and 103 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Proteoglycans in cancer
| Copanlisib | 121 1件: 121 💬85. Proteoglycans in cancer
|
||||||||||||||
| 86 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Rap1 signaling pathway
| Copanlisib | 121 1件: 121 💬86. Rap1 signaling pathway
|
||||||||||||||
| 87 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Ras signaling pathway
| Copanlisib | 121 1件: 121 💬87. Ras signaling pathway
|
||||||||||||||
| 88 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Regulation of actin cytoskeleton
| Copanlisib | 121 1件: 121 💬88. Regulation of actin cytoskeleton
|
||||||||||||||
| 89 | Regulation of lipolysis in adipocytes 💬 13 genes, 71 drugs (DrugBank) and 79 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Regulation of lipolysis in adipocytes
| Copanlisib | 121 1件: 121 💬89. Regulation of lipolysis in adipocytes
|
||||||||||||||
| 90 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Relaxin signaling pathway
| Copanlisib | 121 1件: 121 💬90. Relaxin signaling pathway
|
||||||||||||||
| 91 | Renal cell carcinoma 💬 12 genes, 16 drugs (DrugBank) and 26 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Renal cell carcinoma
| Copanlisib | 121 1件: 121 💬91. Renal cell carcinoma
|
||||||||||||||
| 92 | Salmonella infection 💬 30 genes, 46 drugs (DrugBank) and 75 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Salmonella infection
| Copanlisib | 121 1件: 121 💬92. Salmonella infection
|
||||||||||||||
| 93 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
SLC6A4 1件: SLC6A4 💬Serotonergic synapse
|
Desipramine hydrochloride Desipramine hydrochloride 💬Serotonergic synapse
| Desipramine | 121 1件: 121 💬93. Serotonergic synapse
|
||||||||||||||
| 94 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
SLC6A4 1件: SLC6A4 💬Serotonergic synapse
|
Desipramine Desipramine 💬Serotonergic synapse
| Desipramine | 121 1件: 121 💬93. Serotonergic synapse
|
||||||||||||||
| 95 | Shigellosis 💬 29 genes, 51 drugs (DrugBank) and 92 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Shigellosis
| Copanlisib | 121 1件: 121 💬95. Shigellosis
|
||||||||||||||
| 96 | Signaling pathways regulating pluripotency of stem cells 💬 21 genes, 36 drugs (DrugBank) and 62 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Signaling pathways regulating pluripotency of stem cells
| Copanlisib | 121 1件: 121 💬96. Signaling pathways regulating pluripotency of stem cells
|
||||||||||||||
| 97 | Small cell lung cancer 💬 16 genes, 43 drugs (DrugBank) and 64 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Small cell lung cancer
| Copanlisib | 121 1件: 121 💬97. Small cell lung cancer
|
||||||||||||||
| 98 | Sphingolipid signaling pathway 💬 32 genes, 57 drugs (DrugBank) and 80 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Sphingolipid signaling pathway
| Copanlisib | 121 1件: 121 💬98. Sphingolipid signaling pathway
|
||||||||||||||
| 99 | Spinocerebellar ataxia 💬 18 genes, 29 drugs (DrugBank) and 74 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Spinocerebellar ataxia
| Copanlisib | 121 1件: 121 💬99. Spinocerebellar ataxia
|
||||||||||||||
| 100 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 2件: SLC6A2, SLC6A4 💬
|
Desipramine hydrochloride Desipramine hydrochloride 💬Synaptic vesicle cycle
| Desipramine | 121 1件: 121 💬100. Synaptic vesicle cycle
|
||||||||||||||
| 101 | Synaptic vesicle cycle 💬 8 genes, 34 drugs (DrugBank) and 42 diseases |
SLC6A2 2件: SLC6A2, SLC6A4 💬
|
Desipramine Desipramine 💬Synaptic vesicle cycle
| Desipramine | 121 1件: 121 💬100. Synaptic vesicle cycle
|
||||||||||||||
| 102 | T cell receptor signaling pathway 💬 38 genes, 59 drugs (DrugBank) and 84 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬T cell receptor signaling pathway
| Copanlisib | 121 1件: 121 💬102. T cell receptor signaling pathway
|
||||||||||||||
| 103 | Thyroid hormone signaling pathway 💬 25 genes, 45 drugs (DrugBank) and 73 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Thyroid hormone signaling pathway
| Copanlisib | 121 1件: 121 💬103. Thyroid hormone signaling pathway
|
||||||||||||||
| 104 | TNF signaling pathway 💬 23 genes, 61 drugs (DrugBank) and 90 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬TNF signaling pathway
| Copanlisib | 121 1件: 121 💬104. TNF signaling pathway
|
||||||||||||||
| 105 | Toll-like receptor signaling pathway 💬 41 genes, 65 drugs (DrugBank) and 79 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Toll-like receptor signaling pathway
| Copanlisib | 121 1件: 121 💬105. Toll-like receptor signaling pathway
|
||||||||||||||
| 106 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Type II diabetes mellitus
| Copanlisib | 121 1件: 121 💬106. Type II diabetes mellitus
|
||||||||||||||
| 107 | VEGF signaling pathway 💬 23 genes, 56 drugs (DrugBank) and 94 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬VEGF signaling pathway
| Copanlisib | 121 1件: 121 💬107. VEGF signaling pathway
|
||||||||||||||
| 108 | Viral carcinogenesis 💬 32 genes, 31 drugs (DrugBank) and 58 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Viral carcinogenesis
| Copanlisib | 121 1件: 121 💬108. Viral carcinogenesis
|
||||||||||||||
| 109 | Yersinia infection 💬 27 genes, 45 drugs (DrugBank) and 79 diseases |
PIK3CA 2件: PIK3CA, PIK3CD 💬
|
Copanlisib Copanlisib 💬Yersinia infection
| Copanlisib | 121 1件: 121 💬109. Yersinia infection
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
AGE-RAGE signaling pathway in diabetic complications
28 genes, 55 drugs (DrugBank) and 96 diseases
Aldosterone-regulated sodium reabsorption
13 genes, 17 drugs (DrugBank) and 30 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amoebiasis
20 genes, 32 drugs (DrugBank) and 71 diseases
AMPK signaling pathway
16 genes, 56 drugs (DrugBank) and 95 diseases
Apoptosis
17 genes, 31 drugs (DrugBank) and 64 diseases
Autophagy - animal
14 genes, 20 drugs (DrugBank) and 67 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 75 diseases
B cell receptor signaling pathway
19 genes, 39 drugs (DrugBank) and 68 diseases
Bacterial invasion of epithelial cells
7 genes, 10 drugs (DrugBank) and 19 diseases
Breast cancer
22 genes, 63 drugs (DrugBank) and 80 diseases
C-type lectin receptor signaling pathway
27 genes, 66 drugs (DrugBank) and 102 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
Carbohydrate digestion and absorption
13 genes, 21 drugs (DrugBank) and 33 diseases
Cellular senescence
34 genes, 46 drugs (DrugBank) and 96 diseases
Central carbon metabolism in cancer
19 genes, 37 drugs (DrugBank) and 65 diseases
Chagas disease
31 genes, 56 drugs (DrugBank) and 87 diseases
Chemical carcinogenesis - reactive oxygen species
25 genes, 39 drugs (DrugBank) and 51 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Chemokine signaling pathway
23 genes, 38 drugs (DrugBank) and 64 diseases
Choline metabolism in cancer
11 genes, 30 drugs (DrugBank) and 61 diseases
Cholinergic synapse
32 genes, 64 drugs (DrugBank) and 81 diseases
Chronic myeloid leukemia
17 genes, 23 drugs (DrugBank) and 36 diseases
Colorectal cancer
14 genes, 26 drugs (DrugBank) and 59 diseases
Coronavirus disease - COVID-19
54 genes, 108 drugs (DrugBank) and 105 diseases
Diabetic cardiomyopathy
28 genes, 48 drugs (DrugBank) and 79 diseases
Endometrial cancer
10 genes, 20 drugs (DrugBank) and 28 diseases
Epstein-Barr virus infection
67 genes, 90 drugs (DrugBank) and 82 diseases
ErbB signaling pathway
14 genes, 28 drugs (DrugBank) and 62 diseases
Estrogen signaling pathway
21 genes, 81 drugs (DrugBank) and 73 diseases
Fc epsilon RI signaling pathway
19 genes, 50 drugs (DrugBank) and 68 diseases
Fc gamma R-mediated phagocytosis
9 genes, 14 drugs (DrugBank) and 20 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Focal adhesion
31 genes, 51 drugs (DrugBank) and 52 diseases
FoxO signaling pathway
25 genes, 43 drugs (DrugBank) and 60 diseases
Gastric cancer
22 genes, 40 drugs (DrugBank) and 66 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 64 diseases
GnRH secretion
22 genes, 47 drugs (DrugBank) and 56 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 100 diseases
Hepatitis B
43 genes, 65 drugs (DrugBank) and 87 diseases
Hepatitis C
36 genes, 70 drugs (DrugBank) and 87 diseases
Hepatocellular carcinoma
21 genes, 32 drugs (DrugBank) and 67 diseases
Herpes simplex virus 1 infection
70 genes, 80 drugs (DrugBank) and 107 diseases
HIF-1 signaling pathway
26 genes, 56 drugs (DrugBank) and 87 diseases
Hormone signaling
66 genes, 211 drugs (DrugBank) and 153 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Human immunodeficiency virus 1 infection
50 genes, 57 drugs (DrugBank) and 95 diseases
Human papillomavirus infection
51 genes, 106 drugs (DrugBank) and 115 diseases
Human T-cell leukemia virus 1 infection
59 genes, 74 drugs (DrugBank) and 96 diseases
Inflammatory mediator regulation of TRP channels
25 genes, 53 drugs (DrugBank) and 65 diseases
Influenza A
65 genes, 78 drugs (DrugBank) and 98 diseases
Inositol phosphate metabolism
4 genes, 5 drugs (DrugBank) and 10 diseases
Insulin resistance
19 genes, 38 drugs (DrugBank) and 100 diseases
Insulin signaling pathway
12 genes, 28 drugs (DrugBank) and 71 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Kaposi sarcoma-associated herpesvirus infection
60 genes, 94 drugs (DrugBank) and 118 diseases
Leukocyte transendothelial migration
18 genes, 23 drugs (DrugBank) and 44 diseases
Lipid and atherosclerosis
51 genes, 71 drugs (DrugBank) and 103 diseases
Longevity regulating pathway
11 genes, 22 drugs (DrugBank) and 71 diseases
Longevity regulating pathway - multiple species
11 genes, 18 drugs (DrugBank) and 66 diseases
Measles
42 genes, 63 drugs (DrugBank) and 68 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 42 diseases
MicroRNAs in cancer
33 genes, 75 drugs (DrugBank) and 90 diseases
mTOR signaling pathway
14 genes, 33 drugs (DrugBank) and 95 diseases
Natural killer cell mediated cytotoxicity
44 genes, 50 drugs (DrugBank) and 86 diseases
Neuroactive ligand signaling
92 genes, 239 drugs (DrugBank) and 117 diseases
Neurotrophin signaling pathway
22 genes, 29 drugs (DrugBank) and 37 diseases
Neutrophil extracellular trap formation
36 genes, 46 drugs (DrugBank) and 77 diseases
Non-alcoholic fatty liver disease
23 genes, 52 drugs (DrugBank) and 95 diseases
Non-small cell lung cancer
21 genes, 40 drugs (DrugBank) and 58 diseases
Osteoclast differentiation
38 genes, 86 drugs (DrugBank) and 102 diseases
Pancreatic cancer
19 genes, 40 drugs (DrugBank) and 84 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
PD-L1 expression and PD-1 checkpoint pathway in cancer
35 genes, 66 drugs (DrugBank) and 100 diseases
Phosphatidylinositol signaling system
5 genes, 6 drugs (DrugBank) and 11 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Platelet activation
25 genes, 67 drugs (DrugBank) and 64 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Progesterone-mediated oocyte maturation
14 genes, 38 drugs (DrugBank) and 46 diseases
Prolactin signaling pathway
19 genes, 43 drugs (DrugBank) and 70 diseases
Prostate cancer
24 genes, 57 drugs (DrugBank) and 89 diseases
Proteoglycans in cancer
33 genes, 73 drugs (DrugBank) and 103 diseases
Rap1 signaling pathway
45 genes, 113 drugs (DrugBank) and 98 diseases
Ras signaling pathway
37 genes, 64 drugs (DrugBank) and 70 diseases
Regulation of actin cytoskeleton
35 genes, 82 drugs (DrugBank) and 81 diseases
Regulation of lipolysis in adipocytes
13 genes, 71 drugs (DrugBank) and 79 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
Renal cell carcinoma
12 genes, 16 drugs (DrugBank) and 26 diseases
Salmonella infection
30 genes, 46 drugs (DrugBank) and 75 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Shigellosis
29 genes, 51 drugs (DrugBank) and 92 diseases
Signaling pathways regulating pluripotency of stem cells
21 genes, 36 drugs (DrugBank) and 62 diseases
Small cell lung cancer
16 genes, 43 drugs (DrugBank) and 64 diseases
Sphingolipid signaling pathway
32 genes, 57 drugs (DrugBank) and 80 diseases
Spinocerebellar ataxia
18 genes, 29 drugs (DrugBank) and 74 diseases
Synaptic vesicle cycle
8 genes, 34 drugs (DrugBank) and 42 diseases
T cell receptor signaling pathway
38 genes, 59 drugs (DrugBank) and 84 diseases
Thyroid hormone signaling pathway
25 genes, 45 drugs (DrugBank) and 73 diseases
TNF signaling pathway
23 genes, 61 drugs (DrugBank) and 90 diseases
Toll-like receptor signaling pathway
41 genes, 65 drugs (DrugBank) and 79 diseases
Type II diabetes mellitus
14 genes, 42 drugs (DrugBank) and 94 diseases
VEGF signaling pathway
23 genes, 56 drugs (DrugBank) and 94 diseases
Viral carcinogenesis
32 genes, 31 drugs (DrugBank) and 58 diseases
Yersinia infection
27 genes, 45 drugs (DrugBank) and 79 diseases
